MIT Biologists Discovered Colon Cancer Pathway
Researchers identified a cellular mechanism that allows colorectal cancer to metastasize.
Updated on Sept. 24, 2026 in Cancer
Live Poll
Do you believe individual diet and lifestyle choices are the primary drivers of cancer progression?
MIT biologists have identified a cellular pathway controlled by the protein YAP1 that enables colorectal cancer to spread beyond its original tumor site. This mechanism, which normally aids in tissue repair, allows cancer cells to metastasize when triggered.
Why it matters
Understanding this pathway could lead to new treatments that stop the spread of cancer, addressing a major challenge in patient care. Tumor cells effectively hijack a regenerative program meant to rebuild the intestinal lining after an injury.
Researchers found that YAP1 is more active in metastatic cancer cells, while patients with higher body mass index show increased expression of genes activated by this pathway.
The players
MIT
The Massachusetts Institute of Technology is a private research university located in Cambridge that hosts major scientific laboratories.
The details
High-fat diets trigger enzymes that produce ceramides, which release a molecular brake keeping YAP1 inactive. Once active, YAP1 enters the cell nucleus to switch on genes that allow cancer to spread, a process demonstrated in both mouse models and human tumor organoids.
Timeline
September 24, 2026: Study published in the journal Science.
Deeper Dive
This discovery links environmental factors like diet to the mechanics of the YAP1 signaling pathway. By identifying how tumor cells exploit a regenerative program, this research redefines the metabolic triggers behind cancer cell migration.
Future therapeutic developments may focus on inhibiting enzymes like DEGS1 and DEGS2 to prevent cancer spread. Patients should consult their doctors regarding diet and weight management, which are linked to the activation of these metastatic pathways.
The takeaway
This study reveals how simple dietary factors can influence complex cancer progression at a cellular level. It suggests that blocking specific enzyme-driven pathways could eventually serve as a critical strategy to prevent relapse in cancer patients.
Further reading
Learn more about advancements in oncology research within our Cancer section.
Live Poll
Do you believe individual diet and lifestyle choices are the primary drivers of cancer progression?
